Forecast to Publish a Notice of Funding Opportunity for The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
Lead a multi-site clinical trial network through NIH's ETCTN program if your institution has mature clinical research infrastructure and wants to shape experimental drug development.
Report stale or inaccurate summary
What this is
The Experimental Therapeutics Clinical Trials Network (ETCTN) seeks lead academic organizations to coordinate and manage clinical trial networks evaluating experimental therapeutic approaches. This is a high-level, coordinating role requiring substantial clinical trial infrastructure and experience. The award mechanism is UM1, indicating a large cooperative agreement with significant NIH involvement in network governance and oversight. This is not suitable for independent researchers or small teams without established clinical trial capabilities.
Who can apply
Eligible applicants are academic organizations and institutions with established capacity to serve as lead coordinating centers for multi-site clinical trial networks. Individual researchers, small teams, and non-academic entities are not suitable for this opportunity.
Topics: clinical trials · experimental therapeutics · um1 grant · nih funding · academic research network · drug development
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.